Valuation
- Market cap
- 26,983,000
- Revenue TTM
- $0
- Net income TTM
- $-26,310,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 50,448
- Avg volume
- 128,710
- Day's range
- $3.02 – $3.26
- Shares out
- 8,732,000
- Stochastic %K
- 8%
- Beta
- 1.27
- Analysts
- —
- Price target
- $40.00
Company profile
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...
Show more
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the
clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 604 921 1810
- Website
- https://briacell.com
- Address
- Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
Latest news
No headlines yet.
Stocktwits
FredFlintstock
Nov 4, 11:40 AM
$BCTX on to reverse split land!
0 replies
JediGreen
Nov 4, 8:53 AM
$BCTX 🎶 Where going to ride ride like the one eye jack of diamonds with the devil close behind where going to ride. 🎶
0 replies
smallpower17
Nov 3, 9:13 PM
$BCTX Interesting that BriaCell did their last Renmark presentation on Sept 29 and they are already going to do another one on Nov 12. Seems like a very bullish signal to me. About to get exciting!
0 replies
AliceFireSteam
Nov 3, 9:05 PM
$BCTX added, 6800 shares now, thanks for the drop
0 replies
SmallCapGrowth
Nov 3, 6:32 PM
$BCTX and BriaPro will showcase 4 preclinical presentations at #SITC2026, highlighting anti-cancer activity across breast, prostate and lung cancer models. Data further supports the potential of Bria-OTS+™ and next-generation immunotherapy programs.
News: https://bit.ly/4A9Lfir
0 replies
Merlintrader
Nov 3, 5:53 PM
BriaCell
$BCTX will present four posters at SITC.
The posters are set for Nov 6 and Nov 7.
Shares closed at
$3.09 on Monday, below the SMA50 and below the SMA200, RSI 33.
More details in our hub.
Not investment advice.
